PRE — PRENETICS GLOBAL LTD (Healthcare >> Diagnostics & Research)
PRE FAQ
What is PRE's ROE?
PRENETICS GLOBAL LTD reports a Return on Equity (ROE) of -43.56%.
What is PRE's dividend yield?
PRENETICS GLOBAL LTD offers a dividend yield of 0.00%.
What is PRE's Deepscope Quality Score?
Deepscope rates PRE's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PRE?
Deepscope's AI Timing Score for PRE is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PRE belong to?
PRENETICS GLOBAL LTD is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 19.86
Price
-0.93
(-4.47%)
Day Change
|
|
|---|
PRE, the overall quality is not good ( Quality = 15) but the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 95 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 19.86 |
| PBV / Sector |
1.93 / -23.44
|
| Earning Per Share | -4.47 |
| PE / Sector |
N/A / 37.86
|
| PEG or PE/Growth / Sector |
N/A / 1.41
|
| Average 1M Daily Value |
5.20 M
GREAT
|
| Average 1W Daily Value |
5.75 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:07 |
| Symbol | PRE |
| Name | PRENETICS GLOBAL LTD |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 15.42 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 337.63 / 32,142.66 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Unit 703-706, K11 Atelier King?s Road, Quarry Bay, Hong Kong
Phone: 852 2210 9588
Website: https://www.prenetics.com
Employees: 98
Description: Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
Google